Menu
Currency
GWAS Study

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.

Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al.

19648918 PubMed ID
GWAS Study Type
7823 Participants
76 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AL
Amundadottir L
KP
Kraft P
SR
Stolzenberg-Solomon RZ
FC
Fuchs CS
PG
Petersen GM
AA
Arslan AA
BH
Bueno-de-Mesquita HB
GM
Gross M
HK
Helzlsouer K
JE
Jacobs EJ
LA
LaCroix A
ZW
Zheng W
AD
Albanes D
BW
Bamlet W
BC
Berg CD
BF
Berrino F
BS
Bingham S
BJ
Buring JE
BP
Bracci PM
CF
Canzian F
CF
Clavel-Chapelon F
CS
Clipp S
CM
Cotterchio M
DA
de Andrade M
DE
Duell EJ
FJ
Fox JW
GS
Gallinger S
GJ
Gaziano JM
GE
Giovannucci EL
GM
Goggins M
GC
González CA
HG
Hallmans G
HS
Hankinson SE
HM
Hassan M
HE
Holly EA
HD
Hunter DJ
HA
Hutchinson A
JR
Jackson R
JK
Jacobs KB
JM
Jenab M
KR
Kaaks R
KA
Klein AP
KC
Kooperberg C
KR
Kurtz RC
LD
Li D
LS
Lynch SM
MM
Mandelson M
MR
McWilliams RR
MJ
Mendelsohn JB
MD
Michaud DS
OS
Olson SH
OK
Overvad K
PA
Patel AV
PP
Peeters PH
RA
Rajkovic A
RE
Riboli E
RH
Risch HA
SX
Shu XO
TG
Thomas G
TG
Tobias GS
TD
Trichopoulos D
VD
Van Den Eeden SK
VJ
Virtamo J
WJ
Wactawski-Wende J
WB
Wolpin BM
YH
Yu H
YK
Yu K
ZA
Zeleniuch-Jacquotte A
CS
Chanock SJ
HP
Hartge P
HR
Hoover RN
Chapter II

Abstract

Summary of the research findings

We conducted a two-stage genome-wide association study of pancreatic cancer, a cancer with one of the lowest survival rates worldwide. We genotyped 558,542 SNPs in 1,896 individuals with pancreatic cancer and 1,939 controls drawn from 12 prospective cohorts plus one hospital-based case-control study. We conducted a combined analysis of these groups plus an additional 2,457 affected individuals and 2,654 controls from eight case-control studies, adjusting for study, sex, ancestry and five principal components. We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28). This SNP maps to the first intron of the ABO blood group gene. Our results are consistent with earlier epidemiologic evidence suggesting that people with blood group O may have a lower risk of pancreatic cancer than those with groups A or B.

1,771 European ancestry cases, 1,805 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

7823
Total Participants
GWAS
Study Type
Yes
Replicated
2,120 European ancestry cases, 2,127 European ancestry controls
Replication Participants
European
Ancestry
Finland, U.S., Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.